A Review on Targeting Nanoparticles for Breast Cancer

Author(s): Hasanain Gomhor J. Alqaraghuli, Soheila Kashanian*, Ronak Rafipour.

Journal Name: Current Pharmaceutical Biotechnology

Volume 20 , Issue 13 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Chemotherapeutic agents have been used extensively in breast cancer remedy. However, most anticancer drugs cannot differentiate between cancer cells and normal cells, leading to toxic side effects. Also, the resulted drug resistance during chemotherapy reduces treatment efficacy. The development of targeted drug delivery offers great promise in breast cancer treatment both in clinical applications and in pharmaceutical research. Conjugation of nanocarriers with targeting ligands is an effective therapeutic strategy to treat cancer diseases. In this review, we focus on active targeting methods for breast cancer cells through the use of chemical ligands such as antibodies, peptides, aptamers, vitamins, hormones, and carbohydrates. Also, this review covers all information related to these targeting ligands, such as their subtypes, advantages, disadvantages, chemical modification methods with nanoparticles and recent published studies (from 2015 to present). We have discussed 28 different targeting methods utilized for targeted drug delivery to breast cancer cells with different nanocarriers delivering anticancer drugs to the tumors. These different targeting methods give researchers in the field of drug delivery all the information and techniques they need to develop modern drug delivery systems.

Keywords: Breast cancer, drug delivery, tumor targeting methods, anticancer drug, targeted therapy, targeted drug delivery.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [1087 - 1107]
Pages: 21
DOI: 10.2174/1389201020666190731130001
Price: $58

Article Metrics

PDF: 11